Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference ...
Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine ...
Frontiers Science Center for Synthetic Biology (Ministry of Education), Key Laboratory of Systems Bioengineering, and School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, ...